Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab  Dan Turner, Anne M. Griffiths,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Volume 133, Issue 2, Pages (August 2007)
The Role of Psychosocial Care in Adapting to Health Care Reform
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Saurabh Dawra, Vishal Sharma, Usha Dutta 
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis  Jeffrey Hyams, Lakshmi Damaraju, Marion Blank,
Evidence for Endoscopic Ulcers as Meaningful Surrogate Endpoint for Clinically Significant Upper Gastrointestinal Harm  Andrew Moore, Ingvar Bjarnason,
Pichamol Jirapinyo, Christopher C. Thompson 
Aaron P. Thrift, Thomas L. Vaughan, Lesley A. Anderson, David C
Laura Rosenberg, Kavinderjit S
Volume 133, Issue 2, Pages (August 2007)
A Shocking Cystory Clinical Gastroenterology and Hepatology
Fernando Velayos, Uma Mahadevan 
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Pushing the Pedal to the Metal: Should We Accelerate Infliximab Therapy for Patients With Severe Ulcerative Colitis?  Hans H. Herfarth, MD, PhD  Clinical.
High Risk Ulcer Bleeding: When Is Second-Look Endoscopy Recommended?
Volume 155, Issue 4, Pages (October 2018)
Judy A. Trieu, Mohammad Bilal, Ali Hashmi 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease  Elana A. Maser, Renata Villela,
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Endoscopy 20 Years Into the Future
Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s Disease  Inbar Weinstein-Nakar, Gili Focht,
Activity-Based Costing and Management in a Hospital-Based GI Unit
A Multibiomarker Risk Score Helps Predict Risk for Barrett’s Esophagus
An Association Between Microscopic Colitis and Celiac Disease
Endoscopic Therapy for Barrett's Esophagus
Francisco A. Sylvester, Scott Leopold, Miriam Lincoln, Jeffrey S
Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis  John Gubatan, Shuji Mitsuhashi, Talia Zenlea,
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima 
Gastroenterology in a New Era of Accountability: Part 2
Changes in Fatigue Over 2 Years Are Associated With Activity of Inflammatory Bowel Disease and Psychological Factors  Lesley A. Graff, Ian Clara, John.
Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis  Gary R. Lichtenstein,
Volume 147, Issue 6, Pages e5 (December 2014)
New Models of Gastroenterology Practice
Relationship Between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer  Shari S. Rogal, Paul F. Pinsky, Robert E.
Prevalence and Predictors of Esophageal Varices in Patients With Primary Biliary Cirrhosis  Cynthia Levy, Claudia O. Zein, Justin Gomez, Consuelo Soldevila–Pico,
Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis  Michael J. Stewart, Cynthia.
Raina Shivashankar, Sahil Khanna, Patricia P. Kammer, W
Neovaginal Sparing in a Transgender Woman With Ulcerative Colitis
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Issue Highlights Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
Elizabeth Mileti, Philip Rosenthal, Marion G. Peters 
An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis  David J. Gibson, Zaid.
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity  Severine Vermeire, Stefan Schreiber,
Hannah I. Awai, Kimberly P. Newton, Claude B
John S. Kane, Olorunda Rotimi, Simon M
James Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu, James Lowder 
Thrombocytopenia With Abnormal Liver Function Tests
Marina Somin, Nadia Sokolowski, Stephen D.H. Malnick 
Walter Reinisch, Jean-Frederic Colombel, William J
Volume 132, Issue 3, Pages (March 2007)
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Medical Therapy for Refractory Pediatric Crohn’s Disease
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
Issue Highlights Clinical Gastroenterology and Hepatology
The Role of Psychosocial Care in Adapting to Health Care Reform
Klaus Mönkemüller, Helmut Neumann, Lucia C. Fry 
An Unusual Skin Manifestation in a Patient With Ulcerative Colitis
Presentation transcript:

Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab  Dan Turner, Anne M. Griffiths, Gigi Veerman, Jewel Johanns, Lakshmi Damaraju, Marion Blank, Jeffrey Hyams  Clinical Gastroenterology and Hepatology  Volume 11, Issue 11, Pages 1460-1465 (November 2013) DOI: 10.1016/j.cgh.2013.04.049 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Percentage of children in sustained steroid-free 1-year clinical remission, stratified by those achieving remission at week 8 by the PUCAI and MH. Clinical Gastroenterology and Hepatology 2013 11, 1460-1465DOI: (10.1016/j.cgh.2013.04.049) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Week 8 PUCAI score predicts 1-year steroid-free sustained remission. Clinical Gastroenterology and Hepatology 2013 11, 1460-1465DOI: (10.1016/j.cgh.2013.04.049) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 ROC curve to reflect the ability of the PUCAI, sigmoidoscopy, and CRP at week 8 to predict sustained steroid-free remission defined by PGA (A) or PaGA (B). AUC, area under the curve. Clinical Gastroenterology and Hepatology 2013 11, 1460-1465DOI: (10.1016/j.cgh.2013.04.049) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Concordance between the PUCAI with sigmoidoscopic scoring (A) and with the Mayo scores (B) of 51 children 8 weeks after 3-dose induction with infliximab. Clinical Gastroenterology and Hepatology 2013 11, 1460-1465DOI: (10.1016/j.cgh.2013.04.049) Copyright © 2013 AGA Institute Terms and Conditions

Figure 5 The cutoff values of the PUCAI that correspond best with remission (A) and response (B) defined by the Mayo score. AUROC, area under the ROC curve. Clinical Gastroenterology and Hepatology 2013 11, 1460-1465DOI: (10.1016/j.cgh.2013.04.049) Copyright © 2013 AGA Institute Terms and Conditions